Booth Andrew bought ABCL

August 14, 2026 · Form 4 insider transaction

Booth Andrew bought 37,200 shares of AbCellera Biologics Inc. at $10.32 per share, a transaction worth $383.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.